In the past year Sonavex has landed not one, but two FDA 510(k) clearances for their ultrasound-based medical devices. This first of its kind solution is comprised of two components, EchoMark and EchoSure, that use a customized ultrasound technology to perform real-time blood flow monitoring for postoperative patients.
{iframe}https://biobuzz.io/the-journey-to-commercialization-for-a-novel-medical-device-startup-qa-with-sonavex-ceo-david-narrow/{/iframe}